Business Context and Reporting Period
Company: Bon Natural Life Ltd (Foreign Private Issuer)
Reporting Period: Six months ended March 31, 2022
Business Overview: A bio-ingredient solutions provider engaged in the R&D, manufacturing, and sales of functional active ingredients extracted from natural herb plants for the functional food, personal care, cosmetic, and pharmaceutical industries.
Recent Developments: The company completed a corporate restructuring in late 2021, terminating Variable Interest Entity (VIE) agreements and converting a domestic PRC subsidiary into a Sino-foreign joint venture. The company is currently constructing two new manufacturing plants in Tongchuan and Yumen City.
Key Financial Metrics
| Metric | Six Months Ended Mar 31, 2022 | Six Months Ended Mar 31, 2021 |
|---|---|---|
| Revenue | $13,688,400 | $11,698,830 |
| Gross Profit | $4,035,947 | $3,373,682 |
| Gross Margin | 29.5% | 28.8% |
| Net Income | $2,529,660 | $2,295,199 |
| Operating Cash Flow | ($130,577) | $1,999,769 |
| Cash on Hand (End of Period) | $1,609,079 | $1,040,607 |
| Total Debt Obligations | $4,541,180 | N/A |
| Unpaid Tax Liabilities | ~$3.3 million | ~$5.7 million (as of Mar 31, 2021) |
Material Changes vs. Prior Period
- Revenue Growth: Revenue increased 17.0% year-over-year, driven by a 171.8% surge in bioactive food ingredients and a 24.9% increase in fragrance compounds. This was partially offset by a 28.5% decline in health supplement powder drinks due to raw material shortages.
- Pricing Power: Average selling prices increased significantly across categories (64.1% for fragrance compounds, 79.2% for bioactive ingredients) to offset rising raw material costs and inflation.
- Expense Increases: Operating expenses rose 48.6%, primarily due to a 47.0% increase in General and Administrative expenses (driven by professional fees post-IPO) and a 53.9% increase in R&D expenses (due to outsourcing).
- Cash Flow Shift: Operating cash flow turned negative ($130,577 used) compared to positive ($1.99 million provided) in the prior period, largely due to a $1.8 million decrease in taxes payable (taxes paid in March 2022) and increased inventory and accounts receivable.
- Investing Activities: Significant cash outflow of $1.99 million for investing activities, primarily for construction-in-progress (CIP) of new manufacturing plants and short-term investments.
Guidance, Outlook, and Risks
- Liquidity Outlook: Management believes current cash ($1.6 million) and an unused line of credit ($4.4 million) are sufficient to meet obligations for the next 12 months, including settling tax liabilities and funding CIP projects.
- Capital Expenditures: Approximately $1.0 million is committed for CIP projects within the next 12 months, with total future commitments estimated at $2.0 million.
- COVID-19 Risks: Ongoing pandemic resurgence poses risks to supply chains, logistics, and customer contract execution, potentially causing revenue and cash flow underperformance.
- Supply Chain Constraints: Abnormal wet weather in North China and logistics disruptions have caused shortages in key raw materials (clary sage, stachys affinis), limiting sales volume for fragrance and health supplement products.
- Tax Liabilities: The company has approximately $3.3 million in unpaid tax liabilities expected to be settled with local authorities within one year without penalty.
Key Facts for Investor Verification
- Tax Liability Settlement: Verify the timeline and terms for settling the ~$3.3 million in unpaid tax liabilities with PRC authorities.
- Customer Concentration: Note high concentration risk; three customers accounted for 79.6% of total revenue in the six months ended March 31, 2022.
- Raw Material Supply: Assess the sustainability of supply for key ingredients (clary sage, stachys affinis) given weather-related shortages and logistics disruptions.
- CIP Project Completion: Monitor the completion status and budget adherence of the Tongchuan and Yumen manufacturing plants, which are critical for future capacity.
- Operating Cash Flow: Investigate the drivers behind the shift from positive to negative operating cash flow and the company's ability to generate positive cash flow in the coming quarters.